THE HAGUE, The Netherlands, May 27, 2013 /PRNewswire/ --
Breaking news on Lymphoma (lymph node cancer) and Myeloma (plasma cell cancer) reported at meetings of Scientific Working Groups during the European Hematology Congress in Stockholm, June 13-16, 2013.
In order to support high-quality science, the European Hematology Association (EHA) collaborates with 16 Scientific Working Groups (SWGs) and concentrates on fostering activities directed towards basic and translational research. In simultaneous sessions on Thursday June 13, from 18:30 - 20:00, two of the SWGs will discuss progress in lymphoma and myeloma.
The European Mantle Cell Lymphoma Network will extensively discuss developments in new biological prognostic factors which might prevent over- and under-treatment of patients. Detection of "minimal residual disease" with advanced methods has established individualized risk-dependent treatment strategies. The latest results of treatment of younger patients, both upfront and in the relapse setting, with molecular approaches / smart molecules will be presented, which should lead to an improvement in survival. Special attention will be paid to new treatment options for the elderly with the aim of achieving a better prognosis.
The SWG Myeloma will focus on "Models for drug resistance", representing one of the major problems in maintaining today's effective treatment. New insights into mechanisms of resistance, including identification and prediction of this most unwanted phenomenon, will be discussed. In particular, emerging knowledge of the genetic signature of defined resistant subgroups of patients will be reported. A new preclinical disease model mimicking the clinical condition and providing opportunity to accelerate the development of new drugswill be presented as well as mechanisms through which evolution from "smouldering" disease to aggressive disease takes place.
The Final Program of the Congress is now available online.
The complete press program and releases can be found here
Press Briefing: Friday, June 14, 2013 from 08:30 - 10:00 CET.
The press briefing will take place in Hall C5 at the Stockholmsmässan.
Registration for members of the press is free. To receive your personal link for the online registration, please send an e-mail with your request and media credentials to firstname.lastname@example.org. The Congress Media Guidelines are available here.
SOURCE European Hematology Association